GE Healthcare
 
GE Healthcare Life Sciences Part of GE Healthcare
Location: Home > BioProcess™ > Target Molecules > Vaccines > rHepatitis B Virus-like Particles
BioProcess™
Target Molecules
Antibodies
Plasma Proteins
Recombinant Proteins
Vaccines
Adeno-associated Virus
Gereric Virus Purification Process
Polio Virus
rHepatitis B Virus-like Particles
Sendai Virus
Other

rHepatitis B Virus-like Particles

Purification of recombinant hepatitis B virus-like particles (VLP) can be accomplished by combining cross flow filtration and chromatography. Details of the process are published by Belew et al in Bioseparation (1991) 1: 397-408. The process is scalable and the product meets high purity requirements.